Microcatheter to Recanalization (Procedure Time) Predicts Outcomes in Endovascular Treatment in Patients with Acute Ischemic Stroke: When Do We Stop?

References

1. 1.↵
   1. Alberts MJ,
   2. Hademenos G,
   3. Latchaw RE,
   4. et al

   . Recommendations for the establishment of primary stroke centers: Brain Attack Coalition. JAMA 2000;283:3102–09

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Alberts MJ,
   2. Latchaw RE,
   3. Selman WR,
   4. et al

   . Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597–616

   Abstract/FREE Full Text
3. 3.↵
   1. Schriger DL,
   2. Kalafut M,
   3. Starkman S,
   4. et al

   . Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy. JAMA 1998;279:1293–97

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Hussein HM,
   2. Georgiadis AL,
   3. Vazquez G,
   4. et al

   . Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol 2010;31:454–58

   Abstract/FREE Full Text
5. 5.↵
   1. Miley JT,
   2. Memon MZ,
   3. Hussein HM,
   4. et al

   . A multicenter analysis of “time to microcatheter” for endovascular therapy in acute ischemic stroke. J Neuroimaging 2011;21:159–64

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Burns TC,
   2. Rodriguez GJ,
   3. Patel S,
   4. et al

   . Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: a case-control study. AJNR Am J Neuroradiol 2008;29:1918–24

   Abstract/FREE Full Text
7. 7.↵
   1. Qureshi AI,
   2. Janjua N,
   3. Kirmani JF,
   4. et al

   . Mechanical disruption of thrombus following intravenous tissue plasminogen activator for ischemic stroke. J Neuroimaging 2007;17:124–30

   PubMed
8. 8.↵
   1. Qureshi AI,
   2. Harris-Lane P,
   3. Kirmani JF,
   4. et al

   . Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. Neurosurgery 2006;59:789–96, discussion 96–97

   CrossRefPubMed
9. 9.↵
   1. Qureshi AI,
   2. Siddiqui AM,
   3. Kim SH,
   4. et al

   . Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:322–28

   Abstract/FREE Full Text
10. 10.↵
    1. Qureshi AI,
    2. Hussein HM,
    3. Abdelmoula M,
    4. et al

    . Subacute recanalization and reocclusion in patients with acute ischemic stroke following endovascular treatment. Neurocrit Care 2009;10:195–203

    CrossRefPubMed
11. 11.↵
    1. Qureshi AI,
    2. Suri MF,
    3. Ali Z,
    4. et al

    . Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke: a preliminary feasibility and safety study in a non-human primate model. Neuroradiology 2005;47:845–54.

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Hassan AE,
    2. Zacharatos H,
    3. Rodriguez GJ,
    4. et al

    . A comparison of computed tomography perfusion-guided and time-guided endovascular treatments for patients with acute ischemic stroke. Stroke 2010;41:1673–78

    Abstract/FREE Full Text
13. 13.↵
    1. Qureshi AI,
    2. Suri MF,
    3. Shatla AA,
    4. et al

    . Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerating dosing regimen. Neurosurgery 2000;47:473–76, discussion 477–79

    PubMed
14. 14.↵
    1. Qureshi AI,
    2. Ali Z,
    3. Suri MF,
    4. et al

    . Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001;49:41–48, discussion 48–50

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Furlan A,
    2. Higashida R,
    3. Wechsler L,
    4. et al

    . Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Khatri P,
    2. Abruzzo T,
    3. Yeatts SD,
    4. et al

    . Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066–72

    Abstract/FREE Full Text
17. 17.↵
    1. Leifer D,
    2. Bravata DM,
    3. Connors JJ 3rd.,
    4. et al

    . Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations—a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:849–77

    Abstract/FREE Full Text
18. 18.↵
    1. Derex L,
    2. Adeleine P,
    3. Nighoghossian N,
    4. et al

    . Factors influencing early admission in a French stroke unit. Stroke 2002;33:153–59

    Abstract/FREE Full Text
19. 19.↵
    1. Nguyen TN,
    2. Lanthier S,
    3. Roy D

    . Iatrogenic arterial perforation during acute stroke interventions. AJNR Am J Neuroradiol 2008;29:974–75

    Abstract/FREE Full Text
20. 20.↵
    1. Shi ZS,
    2. Liebeskind DS,
    3. Loh Y,
    4. et al

    . Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy. Stroke 2010;41:2775–81

    Abstract/FREE Full Text
21. 21.↵
    1. Nguyen TN,
    2. Babikian VL,
    3. Romero R,
    4. et al

    . Intra-arterial treatment methods in acute stroke therapy. Front Neurol 2011;2:9

    PubMed
22. 22.↵
    1. Qureshi AI,
    2. Alkawi A,
    3. Hussein HM,
    4. et al

    . Angiographic analysis of intravascular thrombus volume in patients with acute ischemic stroke. J Endovasc Ther 2007;14:475–82

    CrossRefPubMed
23. 23.↵
    1. Broderick JP,
    2. Lu M,
    3. Kothari R,
    4. et al

    . Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke 2000;31:2335–41

    Abstract/FREE Full Text